Together with academic and industry collaborators we are investigating various adjuvants that stimulate immunity, mRNA vaccines and their delivery vehicles, in our model. 

We are also interested in how long immunity lasts after COVID-19 vaccination and how we can extend its duration, particularly in those at risk of severe COVID – the elderly and immunocompromised.

A more thorough understanding of how vaccines and their components work in humans will allow us to improve the efficacy or reduce the side effects of existing vaccines and more rapidly choose optimal vaccine formulations for new disease threats or specific high risk populations.